Over the past few weeks we have been looking at your colleagues’ responses to questions about GLP-1, including mechanisms, interactions, dosing and effectiveness. Over the next two weeks we will examine some of your opinions on starting doses and selecting patients….
We decided to start by looking at your prescribing habits and who would be best to start on GLP-1 therapy.
AACE has indicated in their guidelines that the use of a GLP-1 Analog is indicated first line and when we put the question to our readers, those who had an opinion felt that they were unlikely to recommend GLP-1s as monotherapy. We noted with interest that the prescribers, NP’s and Physicians, were the least likely to recommend first line. In comparison, when we looked at the use of GLP-1 analogs as add on therapy, the NP’s and Physicians were anxious to prescribe, with 80% of physicians and 75% of NP’s likely to use these important medications.
Click below to access other articles in this series:
GLP-1 Knowledge Survey Part V
Copyright © 2011 Diabetes In Control, Inc.